Archive for the 'Asbestos & Mesothelioma Studies' Category

Asbestos & Mesothelioma Studies news feed.

Time Increases Risk for Mesothelioma, Study Finds

Asbestos-related illnesses such as mesothelioma and asbestosis have been known to develop over a period of decades, affecting people years and years since their last exposure. Many studies over the years have suggested that the length of the amount of time that has passed since initial exposure and subsequent symptoms can increase the risk of

more

Giving Cediranib Another Chance

A Phase I study for cediranib, a VEGFR/PDGFR kinase inhibitor, showed promising results in shrinking tumor size and increasing survival rates for those suffering from malignant pleural mesothelioma. This is not the first time cediranib has been studied as a possible treatment for mesothelioma. In 2011/2012 a Phase II trial for cediranib conducted by researchers

more

Calretinin More Effective Than Mesothelin in Detecting Mesothelioma Early

Mesothelioma is a rare and aggressive cancer that is difficult to diagnose because symptoms often mimic other diseases such as pulmonary fibrosis or lung cancer. Pathology reports and biopsies help distinguish this cancer from other illnesses, but often patients will have already developed more serious symptoms because the cancer has spread by the time it

more

Survival Rates Based Upon Subtypes of Mesothelioma

A recent study published in the British Journal of Cancer compared survival rates of mesothelioma patients that received their diagnosis through either cytological or by histological method for those with the epithelioid, biphasic, or sarcomatoid subtype of mesothelioma. The concern is that those with the biphasic subtype of mesothelioma are under diagnosed when epithelioid mesothelioma

more

Phase I Clinical Trial Underway for CAR T-cell Therapy

A Phase I clinical trial for an immunotherapy treatment for malignant pleural mesothelioma and non-small cell lung cancer (NSCLC) is currently underway at the University of Pennsylvania in Philadelphia. Immunotherapy treatments support the body’s immune system response to diseases. It is often looked to as a positive alternative for treating malignancies such as mesothelioma because

more

Pembrolizumab Update: Aduro Biotech Collaborates with Merck

A biopharmaceutical company named Aduro Biotech recently announced its collaboration with Merck to further evaluate the findings for the Phase II trial of KEYTRUDA ® (pembrolizumab) and to combine their own immunotherapy treatment, CRS-207. Information regarding KEYRUDA ® treatment began to circulate late last year when data presented at the 17th World Conference on Lung

more

Bevacizumab (Avastin): Part of a New Treatment Regimen for Mesothelioma Patients

The results of a 2016 Phase III trial of the monoclonal antibody bevacizumab (Avastin) have established another option for treatment for those suffering from malignant pleural mesothelioma. Angiogenesis, which is the formation of new blood vessels, plays a key role in mesothelioma because it allows the tumors and cancer to spread. However, scientists and researchers

more

Surgical Techniques for Mesothelioma

While surgical techniques are not the most common effort when it comes to treating mesothelioma, the pleurectomy/decortication (P/D) is a technique that has been the most successful over the years. A recent study took a look at the different surgical techniques that can be used with P/D and noted the overall effects on the patient.

more

Treatment Used In Multiple Sclerosis May Be Used In Mesothelioma

Although still in the preliminary stages, scientists and researchers are excited to announce recent research involving a treatment that is used for certain types of multiple sclerosis (MS) and its effects on combating mesothelioma. This therapeutic agent is called Immune System Modulator FTY720 (fingolimod) and is interestingly derived from a certain type of fungus called

more

Your Asbestosis Could Lead to Lung Cancer or Mesothelioma

Asbestosis, while not a cancerous condition, is serious and potentially life-threatening chronic disease that is caused by breathing in asbestos fibers. A person who has been diagnosed with asbestosis has a much higher chance of developing lung cancer or pleural mesothelioma, a fatal cancer affecting the lining of the lungs. While not all asbestosis cases

more

Nutritional Status and Tumor Thickness Helps Determine Mesothelioma Prognosis

The overall nutritional health of a patient suffering from mesothelioma can have major impact on how the patient will respond to treatment, which affects patient survival. To determine a patient’s nutritional factors on a more exact basis, researchers and scientists from Japan used a scoring system called Controlling Nutritional Status score, or CONUT. CONUT scores

more

Despite Asbestos Regulations, CDC Reports Increase in Mesothelioma

Mesothelioma is a type of cancer that is specifically caused by asbestos exposure. The cancer affects the lining surrounding various organs and cavities within the body called the mesothelium. Asbestos fibers, which are nearly invisible, sharp, and easily inhaled, become embedded in this soft tissue. The body is unable to break down or expel the

more

Partial Repeal in the ACA Preserves Provisions for Residents in Libby, Montana

The dangers of asbestos have affected thousands of residents in the small town of Libby, Montana for decades. In 1919, the town that was once known for its logging industry discovered vermiculite mines – a naturally occurring mineral that is useful for fire-proofing, wall and loft insulation, and even soil conditioning.  W.R. Grace bought the

more

Immunotherapy Drug Tremelimumab Not As Effective As Hoped

Mesothelioma’s aggressive nature makes it difficult to treat with common cancer treatments such as chemotherapy and radiation. Scientists and researchers are constantly looking for new ways to treat mesothelioma outside of chemotherapy and radiation, such as gene therapy or immunotherapy. Immunotherapy is a novel approach and sometimes a more viable option for those suffering from

more

The Latest Clinical Trial for Nintedanib – Are You a Candidate?

Scientists and researchers are excited over the latest completion of a Phase II clinical trial for those suffering from mesothelioma – an incurable asbestos-caused cancer that has a median survival of only 9 to 12 months.  The LUME-Meso Phase II trial for patients with malignant pleural mesothelioma showed a slight increase in progression-free and overall

more

Last update: March 06, 2014. 08:41:31 pm.